Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2022-12-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a change in the company's largest shareholder (maximum shareholder). It details the transfer of shares, the identity of the new shareholder (SCL Healthcare), the purpose of the acquisition (management participation), and the appointment of new board members. This type of disclosure is a standard regulatory announcement for material corporate changes, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to company-level mergers) or Director's Dealing (which refers to individual insider trades).
2022-12-28 Korean
자산재평가실시결정(자율공시)
Regulatory Filings Classification · 1% confidence The document is a formal announcement regarding a decision to perform an asset revaluation (자산재평가 실시 결정). It provides specific details such as the assets involved, the valuation date, the appraisal firm, and the purpose of the revaluation. This type of disclosure is a regulatory filing regarding corporate financial structure and asset management, which does not fit into specific categories like earnings releases or annual reports, making 'RNS' (Regulatory Filings) the most appropriate classification.
2022-12-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Lee Moon-Sue and special related parties) of the company 'InnoTherapy'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2022-12-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including acquisition of shares and conversion of preferred shares, by a major shareholder (SCL Healthcare) in the company Inotherapy. This falls under the category of Major Shareholding Notification.
2022-12-22 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, specifically regarding a change in the largest shareholder due to a management rights transfer. This document type is classified under 'Major Shareholding Notification' (MRQ) as it tracks significant changes in share ownership levels.
2022-12-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Moon-Sue) and special related parties in the company 'InnoTherapy'. This type of filing is specifically used to notify the market when a significant shareholder's stake changes, which falls under the 'Major Shareholding Notification' category.
2022-12-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.